Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancerDOYLE, Catherine; CRUMP, Michael; PINTILIE, Melania et al.Journal of clinical oncology. 2001, Vol 19, Num 5, pp 1266-1274, issn 0732-183XArticle

The statins as anticancer agentsCHAN, Kelvin K. W; OZA, Amit M; SIU, Lillian L et al.Clinical cancer research. 2003, Vol 9, Num 1, pp 10-19, issn 1078-0432, 10 p.Article

Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancerCAMPOS, Susana; HAMID, Oday; CHARBONNEAU, Claudie et al.Journal of clinical oncology. 2005, Vol 23, Num 24, pp 5597-5604, issn 0732-183X, 8 p.Article

Early palliative care for patients with advanced cancer: a cluster-randomised controlled trialZIMMERMANN, Camilla; SWAMI, Nadia; DONNER, Allan et al.Lancet (British edition). 2014, Vol 383, Num 9930, pp 1721-1730, issn 0140-6736, 10 p.Article

A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancerMACKAY, Helen; HEDLEY, David; WRIGHT, John et al.Clinical cancer research. 2005, Vol 11, Num 15, pp 5526-5533, issn 1078-0432, 8 p.Article

A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in CanadaMAROUN, Jean A; ASCHE, Carl; ROMEYER, Francoise et al.PharmacoEconomics (Auckland). 2003, Vol 21, Num 14, pp 1039-1051, issn 1170-7690, 13 p.Article

Evolution of Clinical Trial Design in Early Drug Development: Systematic Review of Expansion Cohort Use in Single-Agent Phase I Cancer TrialsMANJI, Arif; BRANA, Irene; AMIR, Eitan et al.Journal of clinical oncology. 2013, Vol 31, Num 33, pp 4260-4267, issn 0732-183X, 8 p.Article

Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancerCARMICHAEL, James; POPIELA, Tadeusz; RADSTONE, David et al.Journal of clinical oncology. 2002, Vol 20, Num 17, pp 3617-3627, issn 0732-183XArticle

Liarozole fumarate (R85246): In the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancerGOSS, Paul E; STRASSER, Kathrin; DE COSTER, Roland et al.Breast cancer research and treatment. 2000, Vol 64, Num 2, pp 177-188, issn 0167-6806Article

Intravenous Aflibercept in Patients With Platinum-Resistant, Advanced Ovarian Cancer: Results of a Randomized, Double-Blind, Phase 2, Parallel-Arm StudyTEW, William P; COLOMBO, Nicoletta; ZHENMING SHUN et al.Cancer. 2014, Vol 120, Num 3, pp 335-343, issn 0008-543X, 9 p.Article

The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian CancerBACKEN, Alison; RENEHAN, Andrew G; JAYSON, Gordon C et al.Clinical cancer research (Print). 2014, Vol 20, Num 17, pp 4549-4558, issn 1078-0432, 10 p.Article

Nomograms to Predict Serious Adverse Events in Phase II Clinical Trials of Molecularly Targeted AgentsPOND, Gregory R; SIU, Lillian L; MOORE, Malcolm et al.Journal of clinical oncology. 2008, Vol 26, Num 8, pp 1324-1330, issn 0732-183X, 7 p.Article

Phase II study of activated charcoal to prevent irinotecan-induced diarrheaMICHAEL, Michael; BRITTAIN, Maryamte; NAGAI, Jane et al.Journal of clinical oncology. 2004, Vol 22, Num 21, pp 4410-4417, issn 0732-183X, 8 p.Article

Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumorsRUBIN, Eric H; ROTHERMEL, John; TESFAYE, Fisseha et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9120-9129, issn 0732-183X, 10 p.Article

Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumoursMACKAY, Helen J; HIRTE, Hal; PAN, James et al.European journal of cancer (1990). 2010, Vol 46, Num 9, pp 1573-1579, issn 0959-8049, 7 p.Article

Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combination. CommentaryTOWNSLEY, Carol A; POND, Gregory R; CHRISTIAN, Michaele C et al.Clinical cancer research. 2006, Vol 12, Num 7, issn 1078-0432, 1956-1957, 2141-2149 [11 p.], 1Article

A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervixKNOX, Jennifer J; SIU, Lillian L; CHEN, Eric et al.European journal of cancer (1990). 2005, Vol 41, Num 4, pp 523-530, issn 0959-8049, 8 p.Article

High tumor interstitial fluid pressure identifies cervical cancer patients with improved survival from radiotherapy plus cisplatin versus radiotherapy aloneMILOSEVIC, Michael F; PINTILIE, Melania; HEDLEY, David W et al.International journal of cancer (Print). 2014, Vol 135, Num 7, pp 1692-1699, issn 0020-7136, 8 p.Article

Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatmentMACKAY, Helen J; MCGEE, Jacob; VILLA, Diego et al.Journal of clinical virology. 2011, Vol 50, Num 3, pp 212-216, issn 1386-6532, 5 p.Article

Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumorsPATNAIK, Amita; WARNER, Ellen; OZA, Amit M et al.Journal of clinical oncology. 2000, Vol 18, Num 21, pp 3677-3689, issn 0732-183XArticle

Molecular Determinants of Outcome With Mammalian Target of Rapamycin Inhibition in Endometrial CancerMACKAY, Helen J; EISENHAUER, Elizabeth A; DONGSHENG TU et al.Cancer. 2014, Vol 120, Num 4, pp 603-610, issn 0008-543X, 8 p.Article

Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: A national cancer institute of canada clinical trials group studyCRIPPS, M. Christine; FIGUEREDO, Alvaro T; OZA, Amit M et al.Clinical cancer research. 2002, Vol 8, Num 7, pp 2188-2192, issn 1078-0432Article

Performance Characteristics of Screening Strategies for Lynch Syndrome in Unselected Women With Newly Diagnosed Endometrial Cancer Who Have Undergone Universal Germline Mutation TestingFERGUSON, Sarah E; ARONSON, Melyssa; MOJTAHEDI, Golnessa et al.Cancer. 2014, Vol 120, Num 24, pp 3932-3939, issn 0008-543X, 8 p.Article

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer : A Trial of the California, Chicago, and Princess Margaret Hospital Phase II ConsortiaGARCIA, Agustin A; HIRTE, Hal; SCUDDER, Sidney et al.Journal of clinical oncology. 2008, Vol 26, Num 1, pp 76-82, issn 0732-183X, 7 p.Article

Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid TumorsPLUMMER, Ruth; VIDAL, Laura; REID, Gregory K et al.Clinical cancer research (Print). 2009, Vol 15, Num 9, pp 3177-3183, issn 1078-0432, 7 p.Article